Ashwani Gujral of ashwanigujral.com recommends buying Manpasand Beverages, Bajaj Finserv, Natco Pharma and Hindustan Petroleum Corporation.
Stocks of pharmaceutical companies came under heavy selling pressure today following US President Donald Trump's strong remarks on high prices of medicines and new procedure for bidding on drugs indicating a difficult environment in the US, the largest market for Indian generic drug companies.
Porinju Veliyath, MD & Portfolio Manager, Equity Intelligence India says market is in a very bullish mood and it is possible for the Nifty to touch a new high in a few days.
Sudarshan Sukhani of s2analytics.com advises buying Lupin.
According to Sudarshan Sukhani of s2analytics.com, the correction in pharmaceutical stocks would be an opportunity.
UR Bhatt, MD, Dalton Advisors says, in an interview to CNBC-TV18, that he expects the Nifty to trade in the 5800-6100 range and advises investors to bet on select pharmaceuticals, private banks and the FMCG segment.
Although it was a sluggish start to the weak, technical analyst Sudarshan Sukhani, s2analytics.com believes it is a minor correction or a dip but the trend for the market is still up.
The BSE Sensex and Nifty retraced some of their earlier losses in afternoon trade on Wednesday, tracking positive opening of European equities.